Upload Image (Max 20MB per Image)
MolecularMD has obtained an exclusive license to LKB1 for diagnostic, prognostic and predictive uses in non-small cell lung cancer patients. The Dana-Farber Cancer Institute, the Massachusetts General Hospital, the University of North ...
Tags: MolecularMD, exclusive license, lung cancer patients